RAD
Radiopharm Theranostics Limited
1 day chart
About RAD
Radiopharm Theranostics Limited (RAD) is a Clinical stage radiotherapeutics company which is developing and commercialising a platform of radiopharmaceutical products for both therapeutic and diagnostic applications in precision oncology.
Buy Australian shares starting with RAD. Invest today with a CHESS-sponsored investing platform!
Market Capitalisation
$29M
Price-earnings ratio
-1.10
Dividend yield
NaN%
High today
$0.12
Low today
$0.12
Open price
$0.12
52-week high
$0.22
52-week low
$0.09
Announcements
RAD FAQs
Can I buy RAD shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake platform allows you to buy RAD shares and over 8,000 stocks and ETFs across the ASX and Wall St.
How much is one share of Radiopharm Theranostics Limited?
One share of Radiopharm Theranostics Limited is valued at $0.12.
What is the ticker symbol for Radiopharm Theranostics Limited?
The ticker symbol for Radiopharm Theranostics Limited is RAD.
How do I buy RAD shares in Australia?
To buy RAD stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in RAD
What is the 52-week high for Radiopharm Theranostics Limited stock?
The Radiopharm Theranostics Limited 52-week high stock price is $0.22.
What is the 52-week low for Radiopharm Theranostics Limited stock?
The Radiopharm Theranostics Limited 52-week low stock price is $0.09.
What is the market capitalisation of Radiopharm Theranostics Limited RAD?
As of 28/09/2023 Radiopharm Theranostics Limited has a market cap of $29M.
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.